Musk claimed OpenAI and Altman elected to use the company’s technology “to maximize profits” for Microsoft rather than for the benefit of humanity, adding that its entire line of development “is now veiled in secrecy.”
Experts crictise Elon Musk’s Neuralink over transparency after billionaire says first brain implant works
Musk’s casual Neuralink updates on social media and the company’s failure to publish data go against long standing scientific and ethical protocols and could ultimately stymie progress for all neurotechnology, experts told Forbes.
Neuralink, Musk’s brain interface company that hopes to merge humans with computers, began the first human trial of its technology in January with a view to restoring lost functions like movement and communication to people with paralysis.
The price of Worldcoin’s crypto token has almost tripled in the last seven days as the project celebrates a new user milestone.
Elon Musk took aim at OpenAI CEO Sam Altman again Friday over the company’s decision to abandon its original nonprofit model and make money, stoking a longstanding feud with his fellow OpenAI founder as the firm unveiled a powerful new text-to-video AI tool, Sora.
Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are among 14 companies bidding for NASA contracts as part of the agency’s plans to develop the emerging space economy and lower costs.
GLP-1 injectable drugs like Ozempic and Wegovy made up a significant portion of the company’s annual sales.
“Sports can be safer without drug testing,” the Enhanced Games claims, adding its reformed contest will let “athletes become superheroes.”
Japan’s “Moon Sniper” rover on Monday regained power and has woken up on the Moon, a surprise turnaround for the country’s historic space mission after its successful “pinpoint” landing on the lunar surface more than a week was marred by technical challenges and forced into hibernation.
WHO has warned health officials to prepare to combat a rising tide of measles as falling vaccination rates and increased travel after the Covid-19 pandemic help the dangerous virus stage an alarming comeback, with countries in Europe declaring national emergencies as U.S. experts monitor growing cases at risk of spiraling into bigger outbreaks.